TABLE 1

Patient Demographic Data

Patient	Age (y)	Injected dose (MBq)	Mass (μg)	ER/PR/HER2	Tumor T/N	Tumor SUV	DVR
Dynamic patients
1	59	359	5.38	–/–/–/	1.9	3.4	2.4
2	39	281	0.84	+/+/–/, +/+/–/^*	2.3, 2.5^*	3.0, 3.2^*	1.9, 2.7
3	59	222	3.41	–/–/–/	1.9	1.5	1.4
4	32	178	0.83	+/–/–/	1.1	3.9	1.4
5	57	366	0.53	+/+/–/, +/+/–/^*	3.5, 2.8^*	3.4, 2.7^*	3.7, 2.8
6	58	148	1.91	+/+/–/	1.2	2.1	1.1
7	71	366	0.56	+/+/–/	2.2	2.9	2.0
8	58	370	0.34	+/+/–/	1.7	1.2	1.6
Dosimetry patients
1	49	89	1.39	+/+/–/	2.4	1.2	Not applicable
2	52	185	1.87	+/+/–/	1.9	2.3	Not applicable
3	64	370	2.67	+/+/–/	1.8	2.4	Not applicable
4	49	104	0.83	–/–/–/	1.5	1.6	Not applicable
5	53	329	0.75	–/–/–/	1.5	1.2	Not applicable
6	47	270	1.32	–/–/–/	1.2	0.5	Not applicable
7	68	359	0.90	+/+/–/	1.5	1.2	Not applicable
8	64	370	0.31	+/+/–/	4.0	4.4	Not applicable
9	44	215	0.90	+/+/–/	2.6	1.8	Not applicable
10	62	352	0.54	+/+/–/	4.0	3.2	Not applicable
11	55	315	0.76	+/+/–/	3.2	1.9	Not applicable
12	49	259	0.70	+/+/–/	3.8	2.3	Not applicable

↵* Second breast cancer in patients with 2 breast cancers.